Update in Addiction Medicine for the Primary Care Clinician

  • Adam J. Gordon
  • David A. Fiellin
  • Peter D. Friedmann
  • Marc N. Gourevitch
  • Kevin L. Kraemer
  • Julia H. Arnsten
  • Richard Saitz
  • for the Society of General Internal Medicine’s Substance Abuse Interest Group


substance-related disorders primary health care review literature 


  1. 1.
    Whitlock EP, Polen MR, Green CA, Orleans T, Klein J. Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2004;140(7):557–68.PubMedGoogle Scholar
  2. 2.
    Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004;291(10):1238–45.PubMedCrossRefGoogle Scholar
  3. 3.
    Alcohol, other drugs, and health: current evidence. Available at: http://www.bu.edu/aodhealth/about.html. Accessed June 1, 2008.
  4. 4.
    Gordon AJ, Sullivan LE, Alford DP, et al. Update in addiction medicine for the generalist. J Gen Intern Med. 2007;22(8):1190–94.PubMedCrossRefGoogle Scholar
  5. 5.
    Vinson DC, Kruse RL, Seale JP. Simplifying alcohol assessment: two questions to identify alcohol use disorders. Alcohol Clin Exp Res. 2007;31(8):1392–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Kaner EF, Beyer F, Dickinson HO, et al. Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev. 2007;(2):CD004148.Google Scholar
  7. 7.
    National Institute on Alcohol Abuse and Alcoholism. Helping patients who drink too much: a clinician’s guide (NIH Publication No. 05–3769). Rockville, MD: U.S. Department of Health & Human Services; 2005.Google Scholar
  8. 8.
    Timko C, DeBenedetti A, Billow R. Intensive referral to 12-Step self-help groups and 6-month substance use disorder outcomes. Addiction. 2006;101(5):678–88.PubMedCrossRefGoogle Scholar
  9. 9.
    Friedmann PD, McCullough D, Chin MH, Saitz R. Screening and intervention for alcohol problems. A national survey of primary care physicians and psychiatrists. J Gen Intern Med. 2000;15(2):84–91.PubMedCrossRefGoogle Scholar
  10. 10.
    Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. J Stud Alcohol. 1998;59(6):631–9.Google Scholar
  11. 11.
    Project MATCH secondary a priori hypotheses. Project MATCH Research Group. Addiction. 1997;92(12):1671–98.CrossRefGoogle Scholar
  12. 12.
    Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcohol Clin Exp Res. 1998;22:1300–11.CrossRefGoogle Scholar
  13. 13.
    Timko C, DeBenedetti A. A randomized controlled trial of intensive referral to 12-step self-help groups: one-year outcomes. Drug Alcohol Depend. 2007;90(2–3):270–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Johnson BA, Rosenthal N, Capece JA, et al. Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA. 2007;298(14):1641–51.PubMedCrossRefGoogle Scholar
  15. 15.
    Conigrave KM, Hall WD, Saunders JB. The AUDIT questionnaire: choosing a cut-off score. Alcohol Use Disorder Identification Test. Addiction. 1995;90(10):1349–56.PubMedCrossRefGoogle Scholar
  16. 16.
    Allen JP, Litten RZ, Fertig JB, Babor T. A review of research on the Alcohol Use Disorders Identification Test (AUDIT). Alcohol Clin Exp Res. 1997;21(4):613–9.PubMedGoogle Scholar
  17. 17.
    Johnson BA, Rosenthal N, Capece JA, et al. Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial. Arch Intern Med. 2008;168(11):1188–99.PubMedCrossRefGoogle Scholar
  18. 18.
    Martell BA, O’Connor PG, Kerns RD, et al. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med. 2007;146(2):116–27.PubMedGoogle Scholar
  19. 19.
    Kirsh KL, Whitcomb LA, Donaghy K, Passik SD. Abuse and addiction issues in medically ill patients with pain: attempts at clarification of terms and empirical study. Clin J Pain. 2002;18(4 Suppl):S52–S60.PubMedCrossRefGoogle Scholar
  20. 20.
    Davis WR, Johnson BD. Prescription opioid use, misuse, and diversion among street drug users in New York City. Drug Alcohol Depend. 2008;92(1–3):267–76.PubMedCrossRefGoogle Scholar
  21. 21.
    Becker WC, Sullivan LE, Tetrault JM, Desai RA, Fiellin DA. Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates. Drug Alcohol Depend. 2008;94(1–3):38–47.PubMedCrossRefGoogle Scholar
  22. 22.
    Clausen T, Anchersen K, Waal H. Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study. Drug Alcohol Depend. 2008;94(1–3):151–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Hser YI, Hoffman V, Grella CE, Anglin MD. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry. 2001;58(5):503–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Graham NA, Merlo LJ, Goldberger BA, Gold MS. Methadone- and heroin-related deaths in Florida. Am J Drug Alcohol Abuse. 2008;34(3):347–53.PubMedCrossRefGoogle Scholar
  25. 25.
    Center for Substance Abuse Treatment. Summary report of the meeting: methadone mortality- a reassessment. Available at: http://www.dpt.samhsa.gov/pdf/Methadone_Report_10%2018%2007_Brief%20w%20attch.pdf. Accessed July 1, 2008.
  26. 26.
    Alford DP, LaBelle CT, Richardson JM, et al. Treating homeless opioid dependent patients with buprenorphine in an office-based setting. J Gen Intern Med. 2007;22(2):171–6.PubMedCrossRefGoogle Scholar
  27. 27.
    Mintzer IL, Eisenberg M, Terra M, et al. Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings. Ann Fam Med. 2007;5(2):146–50.PubMedCrossRefGoogle Scholar

Copyright information

© Society of General Internal Medicine 2008

Authors and Affiliations

  • Adam J. Gordon
    • 1
    • 2
  • David A. Fiellin
    • 3
  • Peter D. Friedmann
    • 4
  • Marc N. Gourevitch
    • 5
  • Kevin L. Kraemer
    • 2
  • Julia H. Arnsten
    • 6
  • Richard Saitz
    • 7
    • 8
  • for the Society of General Internal Medicine’s Substance Abuse Interest Group
  1. 1.Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System and Mental Illness Research Education and Clinical CenterVA Pittsburgh Healthcare SystemPittsburghUSA
  2. 2.Center for Research on Health CareUniversity of PittsburghPittsburghUSA
  3. 3.Yale University School of MedicineNew HavenUSA
  4. 4.Center on Systems, Outcomes and Quality in Chronic Disease and Rehabilitation, Providence VA Medical Center, Division of General Internal Medicine, Rhode Island HospitalAlpert Medical School of Brown UniversityProvidenceUSA
  5. 5.New York University School of MedicineNew YorkUSA
  6. 6.Albert Einstein College of Medicine and Montefiore Medical CenterNew YorkUSA
  7. 7.Clinical Addiction Research and Education (CARE) Unit, Section of General Internal MedicineBoston Medical Center and Boston University School of MedicineBostonUSA
  8. 8.Youth Alcohol Prevention Center and Department of EpidemiologyBoston University School of Public HealthBostonUSA

Personalised recommendations